Skip to content
HowShorted

GENOCEA BIOSCIENCES, INC. short interest in 2021

In 2021, GENOCEA BIOSCIENCES, INC.'s disclosed short interest ran from 3.26% of shares outstanding on 15 Jan 2021 to 2.79% on 31 Dec 2021, a change of -0.47 percentage points. The year's high was 3.46% on 29 Jan 2021 and its low 2.54% on 13 Aug 2021, averaging 2.88% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.11 days on 30 Jul 2021. Full history: GENOCEA BIOSCIENCES, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for GENOCEA BIOSCIENCES, INC. in 2021

2021 in figures

Start of year
3.26% (15 Jan 2021)
End of year
2.79% (31 Dec 2021)
Change
-0.47 pp
High
3.46% (29 Jan 2021)
Low
2.54% (13 Aug 2021)
Average
2.88%
Highest days to cover
16.11 (30 Jul 2021)
SEC filings marked
8

Every report in 2021

GENOCEA BIOSCIENCES, INC. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20213.26%2.88
29 Jan 20213.46%2.40
12 Feb 20213.27%2.19results (8-K)
26 Feb 20212.92%2.1110-K filed
15 Mar 20213.23%6.52
31 Mar 20213.11%4.10
15 Apr 20213.11%5.25
30 Apr 20213.26%5.9310-Q filed, results (8-K)
14 May 20213.16%7.27
28 May 20212.99%11.05
15 Jun 20212.87%3.49
30 Jun 20212.81%9.69
15 Jul 20212.80%9.88
30 Jul 20212.59%16.1110-Q filed, results (8-K)
13 Aug 20212.54%12.28
31 Aug 20212.54%9.21
15 Sep 20212.57%5.33
30 Sep 20212.60%6.10
15 Oct 20212.60%9.33
29 Oct 20212.74%9.7710-Q filed, results (8-K)
15 Nov 20212.74%10.31
30 Nov 20212.61%11.93
15 Dec 20212.56%6.14
31 Dec 20212.79%1.00

See also: GENOCEA BIOSCIENCES, INC.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.